Categories Earnings, Health Care

BioTelemetry Q2 earnings exceed estimates on record revenues; stock up 10%

Medical technology company BioTelemetry, Inc. (NASDAQ: BEAT) reported higher earnings and revenues for the June quarter. Earnings topped expectations, while revenues came in line with the forecast. The company’s stock gained about 10% following the announcement.

Adjusted earnings, excluding special items, moved up to $0.53 per share from $0.46 per share in the second quarter of 2018. Analysts had forecast a lower number. Reported profit was $8.3 million or $0.23 per share, compared to $10.4 million or $0.29 per share last year.

Also see: Mastercard Q2 profit, revenue top Street view

Driving the bottom-line growth, revenues advanced to $111.18 million in the second quarter from $101.36 million in the corresponding period of last year, setting a record. The top-line, which increased for 28th consecutive quarter, was broadly in line with the Street view. Growth was primarily driven by the stable demand for the company’s MCT and extended Holter services as well as the addition of the monitoring revenue from Geneva.

Growth was primarily driven by the stable demand for the company’s MCT and extended Holter services

“Our growth momentum continued in the second quarter, with revenue growth of 10%, enabling us to achieve the high end of our guidance.  This revenue growth was once again primarily driven by the strong demand for our MCT and extended Holter services as well as the addition of the monitoring revenue from Geneva, which we acquired in the first quarter,” said CEO Joseph Capper.

Also see: FireEye reports Q2 loss; stock plunges on weak guidance

In the March quarter, the company completed the acquisition of Geneva Healthcare, extending its remote cardiac monitoring reach to the implantable cardiac monitoring market. The deal is expected to reinforce the management’s growth strategy and provides significant revenue growth.

Shares of BioTelemetry hit a record high at the beginning of the year but lost momentum since then. The stock, which lost 25% so far this year, closed Tuesday’s regular session higher and continued to gain in the after-hours.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

What to look for when CVS Health (CVS) reports Q3 earnings

Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain

eBay (EBAY): A few factors that helped drive growth in Q3 2024

Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,

CVX Earnings: Chevron reports lower revenue and profit for Q3 2024

Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top